Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
InflaRx ( (IFRX) ) has provided an update.
On April 23, 2026, InflaRx held its annual general meeting of shareholders, where investors approved the Dutch statutory annual accounts for the year ended December 31, 2025, and reappointed KPMG Accountants N.V. as external auditor for 2026. Shareholders also granted discharge to the board for its 2025 performance and confirmed the mandates of key executive and non-executive directors, reinforcing continuity in the company’s leadership and oversight structures.
The meeting further authorized the board to issue shares, limit or exclude pre-emption rights, and repurchase shares and depository receipts, expanding its corporate finance flexibility. Investors approved amendments to the articles of association that increase authorized share capital and introduce a transitional mechanism for future capital expansion, as well as a new long-term incentive plan for 2026, collectively enhancing InflaRx’s capacity to raise capital, manage its equity base, and retain senior talent.
The most recent analyst rating on (IFRX) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on InflaRx stock, see the IFRX Stock Forecast page.
Spark’s Take on IFRX Stock
According to Spark, TipRanks’ AI Analyst, IFRX is a Neutral.
The score is held back primarily by weak financial performance (minimal revenue, continued losses, and cash burn despite low debt). Technicals are a partial offset with strong momentum and price above key averages, though signals are overbought. Valuation remains constrained by negative earnings and no dividend support.
To see Spark’s full report on IFRX stock, click here.
More about InflaRx
InflaRx N.V., based in Jena, Germany, is a Dutch-law public limited company listed in the United States and focused on biopharmaceutical development. The company operates under an international governance framework, with its statutory accounts audited in the Netherlands and corporate decisions ratified by shareholders at its annual general meetings.
Average Trading Volume: 584,767
Technical Sentiment Signal: Buy
Current Market Cap: $125.1M
For a thorough assessment of IFRX stock, go to TipRanks’ Stock Analysis page.